Zions Bancorporation grew its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 4,273.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,455 shares of the medical research company’s stock after purchasing an additional 3,376 shares during the period. Zions Bancorporation’s holdings in Thermo Fisher Scientific were worth $654,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Edgestream Partners L.P. raised its holdings in shares of Thermo Fisher Scientific by 67.7% during the 1st quarter. Edgestream Partners L.P. now owns 2,851 shares of the medical research company’s stock valued at $438,000 after buying an additional 1,151 shares during the period. Tudor Investment Corp ET AL increased its holdings in Thermo Fisher Scientific by 241.8% during the 1st quarter. Tudor Investment Corp ET AL now owns 8,545 shares of the medical research company’s stock worth $1,313,000 after purchasing an additional 6,045 shares during the last quarter. Flagship Harbor Advisors LLC increased its holdings in Thermo Fisher Scientific by 24.3% during the 1st quarter. Flagship Harbor Advisors LLC now owns 4,750 shares of the medical research company’s stock worth $725,000 after purchasing an additional 930 shares during the last quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund increased its holdings in Thermo Fisher Scientific by 11.2% during the 1st quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund now owns 16,527 shares of the medical research company’s stock worth $2,539,000 after purchasing an additional 1,658 shares during the last quarter. Finally, OLD Mutual Customised Solutions Proprietary Ltd. increased its holdings in Thermo Fisher Scientific by 15.5% during the 1st quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 13,172 shares of the medical research company’s stock worth $2,023,000 after purchasing an additional 1,772 shares during the last quarter. 86.05% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts have issued reports on the company. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, September 18th. Barclays reiterated an “overweight” rating and issued a $215.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Morgan Stanley reiterated an “overweight” rating and issued a $220.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Cowen reiterated a “buy” rating and issued a $200.00 price target on shares of Thermo Fisher Scientific in a report on Friday, September 1st. Finally, Jefferies Group reiterated a “hold” rating and issued a $195.00 price target on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. One investment analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $205.21.

In other news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the sale, the chief executive officer now directly owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.49% of the stock is currently owned by insiders.

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $192.29 on Thursday. Thermo Fisher Scientific Inc. has a 12 month low of $139.88 and a 12 month high of $201.20. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $77,749.00, a price-to-earnings ratio of 21.31, a PEG ratio of 1.78 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the previous year, the business earned $2.03 EPS. The company’s quarterly revenue was up 13.9% compared to the same quarter last year. research analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.

TRADEMARK VIOLATION NOTICE: This story was first reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-shares-bought-by-zions-bancorporation/1776217.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.